Purpose: To investigate the effects of mild-to-moderate cystic fibrosis (CF) on the pulmonary oxygen uptake ( 2 O V  ) kinetics of 7 pediatric patients (13.5 ± 2.8 y) versus 7 healthy matched controls (CON; 13.6 ± 2.4 y). We hypothesized that CF would slow the 
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INTRODUCTION
Maximal O 2 uptake ( 2 O V  max ) is clinically important in patients with cystic fibrosis (CF), given associations with prognosis (26) , risk of hospitalization (25) and health-related quality of life (11) . (34, 17) , pseudorandom binary sequence (PRBS) (22) and constant work rate (CWR) exercise (19, 1) . However, a similar 2 O V  kinetic response to healthy controls (11-15 y) has been documented during intense exercise (7) . Methodological issues may explain these disparities. Firstly, during incremental and PRBS exercise the phase II portion of the 2 O V  response was not isolated, which is critical to reflect the kinetics of muscle O 2 consumption (21). Secondly, the CWR exercise study by Hebestreit and colleagues (19) did not prescribe work rate within physiologically defined exercise intensity domains. Furthermore, semi-recumbent cycling was used which may negate muscle O 2 delivery during exercise, and a mixed age group of 10-33 y, which would comprise a range of pulmonary function characteristics, were tested (19) . (18, 38, 29) , impaired skeletal muscle oxidative capacity in CF is reported (30, 34, 40, 15, 12 (30, 34) . This raises questions regarding the capacity of CF skeletal muscle to increase muscle O 2 extraction during exercise, but this has yet to be evaluated alongside (Tables   1 and 2 ) and 7 controls (CON) ( Values are means ± SD, with the range also displayed where suitable, unless otherwise stated. CFTR, cystic fibrosis transmembrane conductance regulator; P. Aeruginosa; Pseudomonas Aeruginosa; Shwachman score -scoring 4 separate aspects of the disease profile; general activity; physical examination; nutritional status; and chest radiographic findings, using the most recent clinical review information. A total of 100 points represents a perfect score of health; IVABs, intravenous antibiotics; a According to Leeds Criteria, "chronic", > 50% of the preceding 12 months were P. aeruginosa culture positive; "intermittent", ≤50% of the preceding 12 months were P. aeruginosa culture positive; "never", no growth of P. aeruginosa for the previous 12 months, having previously been P. aeruginosa culture positive; "free", P. aeruginosa has never been cultured. b Provides evidence of radiographic chest findings. Maximum score is 20, with 20 being the most severe. 
Experimental protocol
Participants attended the laboratory five times over a two week period, at a similar time of day and separated by 24-48 h. Participants were advised to arrive rested and hydrated, > 2 h postprandial and having refrained from caffeine (> 2 h). All exercise was performed on a cycle ergometer (Lode, Groningen, The Netherlands or Lode Corival (Pediatric), Groningen).
Visit 1: CPET protocol. Following anthropometric and pulmonary function measurements, a combined ramp incremental and supramaximal (S max ) CPET was used to determine 2 O V  max and the gas exchange threshold (GET) (32, 33) . This protocol involved an exhaustive ramp incremental (10- Numed, Sheffield, UK), and expressed as a percentage predicted using appropriate reference values (38) .
Gas exchange and pulse oximetry. Breath-by-breath changes in gas exchange and ventilation were determined using a metabolic cart (Metalyzer 3B Cortex, Biophysik, Leipzig, Germany), which was calibrated each test using gases of known concentration and a 3 L syringe (Hans Rudolph, Kansas City, MO). Fingertip SpO 2% was measured on a beat-by-beat basis at the fingertip using pulse oximetry (NONIN, Avant 4000, NONIN Medical Inc., USA).
Near-infrared spectroscopy. A near-infrared spectrometer (Portamon, Artinis Medical Systems) was used to non-invasively measure [HHb] at the m. vastus lateralis. Details regarding this system have been outlined in our previous work in young people with CF during ramp incremental exercise (34) . Briefly, this system consists of an emission probe, with three light sources emitting two wavelengths of light (760 and 850 nm) and a photon detector. Following cleaning and shaving of the area of interrogation, the wireless emitter-detector unit was placed over the muscle belly, midway between the greater trochanter and lateral epicondyle of the femur. After marking of the placement area, the device was secured with tape (Kinesio ® Tex) and a dark elastic bandage to minimize extraneous light interference with the near-infrared signal. The intensity of incident and transmitted light was recorded at continuously at 10 Hz.
Thoracic Impedance. Beat-by-beat changes in heart rate (HR), SV and ̇ were measured using a bioelectrical impedance cardiography system (PhysioFlow, PF-05, Manatec Biomedical, Paris, France) that has previously been used in CF (e.g.
2). This technique uses a high-frequency (75 kHz)
and low-magnitude (1.8 mA) current across the thorax, to enable changes in thoracic impedance during the cardiac cycle to be recorded. Following preparation of the skin sites, electrodes were positioned on the forehead, base of the neck and above the supraclavicular fossa, and two positioned on the xiphoid process. Another set of two electrodes were used to determine a single electrocardiograph signal at the V1 and V6 positions.
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CPET parameters of aerobic function. (32) and was normalized to fat-free mass (FFM) using the ratio standard method. The GET was identified using the V-slope method (5) were analysed using methodology previously described by our laboratory (3, 8) . Briefly, the four repeat transitions for both MOD and GraphPad Software, San Diego, CA):
. 
RESULTS

Maximal cardiopulmonary exercise testing
Descriptive characteristics and CPET data are presented in Table 2 . There were no differences in body size and composition and lung function between CF and CON. responses during MOD and VH are presented in Figure 1 and the kinetic parameters in Table 3 . There was no significant difference in baseline
between the groups for either MOD or VH exercise (Table 3) . For MOD, CF had no influence on either the phase II τ, TD or MRT.
However, the phase II 
Muscle oxygenation kinetics
The group mean data for [HHb] and the corresponding kinetic parameters are shown in Figure 2 and utilised CWR exercise and isolated phase II, work rate was not prescribed within physiologically defined intensity domains (18) . This process meant patients were likely to be exercising across the MOD-severe intensity domains which, if the intensity was above the GET, would be consistent with our present findings of slowed An interesting finding in this study was that the influence of CF on oxidative muscle metabolism appears to be intensity dependent. This is based on the finding that the phase II This was not observed in the present study and this finding corresponds with earlier studies during incremental exercise using both NIRS (34) and respiratory mass spectroscopy (30) . Whilst this finding shows that the rate of O 2 extraction taking place was not different in CF compared to CON, (D) dynamics of young cystic fibrosis patients (○ white circles) and healthy age-and gendermatched controls (• black circles) during moderate (1) and very heavy (2) intensity cycling exercise. The vertical dotted line denotes the onset of exercise from a 10 W baseline. Data are mean and SD and 30-s averages. * denotes P < 0.05, i.e. significant mean difference between CF patients and healthy controls, whilst + denotes a statistical trend (p = 0.07).
